You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: RE40183


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: RE40183
Title:7-Substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
Abstract:The invention is drawn to 7-substituted-9-(substituted amino)-6-demethyl-6-deoxytetracycline compounds of the formula ##STR00001## wherein R, X, R.sup.5 and R.sup.6 are defined in the specification. The compounds of the invention are useful as broad spectrum antibiotics.
Inventor(s): Hlavka; Joseph J. (Tuxedo Park, NY), Sum; Phaik-Eng (Pomona, NY), Gluzman; Yakov (Upper Saddle River, NJ), Lee; Ving J. (Los Altos, CA), Ross; Adma A. (Airmont, NY)
Assignee: Wyeth Holdings Corporation (Madison, NJ)
Application Number:11/145,508
Patent Claim Types:
see list of patent claims
Compound; Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

When navigating the complex world of U.S. patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the intricacies of patent scope, claim construction, and the broader patent landscape, using the context of U.S. Patent RE40183 as a reference point, although the specific details of this patent will not be the primary focus.

What are Patent Claims?

Patent claims are the heart of a patent application, defining the scope of the invention for which protection is sought. These claims must be clear, concise, and supported by the patent's specification[3].

Types of Patent Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.
  • Multiple Dependent Claims: These claims refer back to more than one independent claim[5].

Measuring Patent Scope

Patent scope is a critical aspect of patent quality and can be measured using several metrics.

Independent Claim Length and Count

Research has shown that independent claim length and the number of independent claims can serve as simple yet effective metrics for measuring patent scope. Narrower claims, as indicated by shorter lengths and fewer counts, are associated with a higher probability of grant and a shorter examination process[3].

Impact of Examination Process

The patent examination process often narrows the scope of patent claims. This is evident from studies showing that the duration of examination is inversely related to the breadth of claims. Longer examinations tend to result in narrower claims[3].

Claim Construction and Interpretation

Claim construction is the process of determining the meaning and scope of patent claims.

Legal Framework

The U.S. Court of Appeals for the Federal Circuit plays a significant role in interpreting patent claims. The court must construe the claims consistently across all asserted patents, ensuring that the construction does not lead to mutually exclusive claims[2].

Example: Vascular Solutions LLC v. Medtronic, Inc.

In this case, the court had to interpret the term "substantially rigid portion" across multiple patents derived from a common application. The decision emphasized the importance of consistent claim construction and the use of functional interpretations where necessary[2].

Patent Allowance Rates and Continuation Procedures

Understanding the probability of receiving a U.S. patent involves analyzing allowance rates and continuation procedures.

Types of Allowance Rates

  • First-Action Allowance Rate: The proportion of progenitor applications allowed without further examination.
  • Progenitor Allowance Rate: The proportion of progenitor applications allowed without any continuation procedure.
  • Family Allowance Rate: The proportion of progenitor applications that produce at least one patent, including outcomes of continuation applications[1].

Continuation Procedures

Continuations can be non-serialized (e.g., Requests for Continued Examination) or serialized (e.g., Continuations-in-Part, Divisional applications). These procedures can significantly complicate the calculation of allowance rates and the overall patent landscape[1].

Patent Quality and Examination Time

The quality of patents is a recurring theme in discussions about the U.S. patent system.

GAO Recommendations

The Government Accountability Office (GAO) has recommended that the USPTO define patent quality more consistently and reassess the time allotted for examination. The USPTO has concurred with these recommendations and has taken steps to implement them, including developing correctness measures and adjusting examination times for certain technology areas[4].

Application Readiness

The USPTO has also studied the impact of application readiness on patent quality. Tools like the Application Readiness Review Form (ARRF) help determine whether an applicant has provided sufficient information for an effective application, thereby influencing the quality and pendency of the patent[4].

Patent Landscape and Technology Fields

Patents are categorized into various technology fields, which can affect their scope and examination process.

Broad Technology Fields

The USPTO aggregates technology classes into broad fields such as Chemical, Drugs and Medical, Electrical and Electronics, Computers and Communications, Mechanical, and a miscellaneous “Other” category. This categorization helps in analyzing trends and challenges specific to each field[1].

Impact of Patent Scope on Innovation

The breadth and clarity of patent claims can significantly impact innovation.

Licensing and Litigation Costs

Overly broad patents with decreased clarity can lead to increased licensing and litigation costs, potentially diminishing incentives for innovation. Narrower, clearer claims, on the other hand, can facilitate smoother licensing and reduce legal disputes[3].

Key Takeaways

  • Patent Claims: Clear and concise claims are essential for defining the scope of an invention.
  • Patent Scope Metrics: Independent claim length and count are useful metrics for measuring patent scope.
  • Claim Construction: Consistent and functional interpretations of claims are crucial for legal clarity.
  • Continuation Procedures: These can complicate allowance rate calculations and the patent landscape.
  • Patent Quality: Defining and ensuring patent quality involves consistent definitions, adequate examination time, and application readiness.
  • Technology Fields: Different fields have unique challenges and trends affecting patent scope and examination.

FAQs

What are the different types of patent claims?

Patent claims can be independent, dependent, or multiple dependent. Independent claims stand alone, dependent claims refer back to an independent claim, and multiple dependent claims refer back to more than one independent claim[5].

How is patent scope measured?

Patent scope can be measured using metrics such as independent claim length and the number of independent claims. Narrower claims are often associated with a higher probability of grant and a shorter examination process[3].

What is the role of continuation procedures in the patent process?

Continuation procedures, such as Requests for Continued Examination (RCEs) and Continuations-in-Part, allow applicants to pursue additional patent protection based on an initial application. These procedures can complicate the calculation of allowance rates[1].

How does the USPTO ensure patent quality?

The USPTO ensures patent quality through measures such as defining correctness standards, reassessing examination times, and using tools like the Application Readiness Review Form (ARRF) to evaluate application readiness[4].

What is the impact of patent scope on innovation?

The breadth and clarity of patent claims can affect innovation by influencing licensing and litigation costs. Clearer, narrower claims can facilitate innovation by reducing legal disputes and costs[3].

Sources

  1. Carley, M., & Hegde, D. "What Is the Probability of Receiving a US Patent?" Yale Journal of Law and Technology, [PDF].
  2. VASCULAR SOLUTIONS LLC v. MEDTRONIC, INC. United States Court of Appeals for the Federal Circuit, [PDF].
  3. Patent Claims and Patent Scope. SSRN, [PDF].
  4. Intellectual Property: Patent Office Should Define Quality, Reassess Examination Time. Government Accountability Office, [PDF].
  5. 35 USC 282: Presumption of validity; defenses. U.S. House of Representatives.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent RE40183

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent RE40183

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0536515 ⤷  Subscribe CA 2006 00027 Denmark ⤷  Subscribe
European Patent Office 0536515 ⤷  Subscribe 91279 Luxembourg ⤷  Subscribe
European Patent Office 0536515 ⤷  Subscribe 300244 Netherlands ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.